Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1382 of 5804
-
New patch could replace fingersticks for 5 days of glucose monitoring
Disease control CompletedThe primary objective of the study is to evaluate the safety and effectiveness of the Biolinq MicroArray Intradermal Continuous Glucose Biowearable System, which is intended to be worn for up to five (5) days (up to 120 hours) in adults with diabetes mellitus (DM). Data collected…
Phase: NA • Sponsor: Biolinq Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Brain wave test could revolutionize hearing checks for children
Diagnosis CompletedHearing loss is one of the most prevalent impairments in the world. The World Health Organization estimates that as of 2020, around 466 million people worldwide are affected by disabling hearing loss, of which 34 million are children. Without appropriate diagnosis and treatment, …
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Diagnosis
Last updated Jun 26, 2026 15:12 UTC
-
New hope for toddlers with bladder nerve damage: mirabegron trial launches
Disease control OngoingPeople with neurogenic detrusor overactivity (NDO) have poor bladder control because of how their nerves to the bladder are wired. This can cause high pressure in the bladder, causing it to leak urine by accident (incontinence). Mirabegron has already been approved for adults wit…
Phase: PHASE3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for rare cancer: drug cocktail targets sarcoma
Disease control Recruiting nowObjective to evaluate the efficacy and safety of candonilimab combined with anlotinib in the treatment of progressive or metastatic soft tissue sarcoma that failed previous first-line standard therapy.
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
3-D brain mapping could sharpen ultrasound treatment for hand tremors
Disease control Recruiting nowThe investigators propose to advance Vim-FUSA (Ventral Intermediate Nucleus - Focused Ultrasound Ablation) with the support of 3-D tractography, a neuroimaging technique to visually represent nerve tracts within the brain. The investigators hypothesize that 3-D tractography Vim-F…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New Parent-Led therapy helps infants with down syndrome babble and talk sooner
Symptom relief CompletedChildren with Down syndrome (DS) face life-long struggles with verbal communication. Babble and speech sound development is delayed, and speech can be difficult to understand. Words emerge late, at 21 months on average, compared to 12 months for typical peers, and vocabulary and …
Phase: NA • Sponsor: Arizona State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Could BCG and MMR vaccines tame COPD inflammation?
Disease control CompletedA randomized, single-blinded clinical pilot study to assess whether vaccination with live attenuated vaccines can induce trained immunity and cause beneficial changes in patients with COPD.
Phase: PHASE4 • Sponsor: Josefin Eklöf • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could a $4 blood pressure pill ease a rare lung disease?
Disease control Recruiting nowThis is a Phase 2, single-center, randomized placebo controlled trial of valsartan (an angiotensin receptor blocker) in adults with pulmonary arterial hypertension. The study will evaluate the safety and clinical efficacy of a 24-week course of valsartan.
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a smartphone app help kidney transplant patients stay healthy?
Disease control OngoingThis is a randomized study to test a smartphone app that a pharmacist will use to help kidney transplant patients track their medications, blood pressures, and blood sugars in those with diabetes. The goal of this study is to improve care and outcomes in kidney transplant patient…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could CBD ease endometriosis pain? new trial aims to find out
Symptom relief Recruiting nowDespite the proliferation of cannabis and cannabinoid products in recent years, little research has been done to determine the impact of these products on womens health conditions, including endometriosis. This study is designed to assess the impact of a custom-formulated, hemp-d…
Phase: PHASE2 • Sponsor: Mclean Hospital • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
Can talking to an avatar help beat eating disorders?
Symptom relief CompletedThe Dialogue Study is a randomized, assessor-blinded parallel-groups superiority clinical trial fulfilling the CONSORT criteria for non-pharmacological treatment. The aim of the trial is to investigate the effect of a new virtual reality based psychotherapy for eating disorders. …
Phase: NA • Sponsor: University Hospital Bispebjerg and Frederiksberg • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New scan could spare men with prostate cancer from unnecessary biopsies
Diagnosis Recruiting nowThis study will be assessing the ability of PSMA-PET CT to determine the absence of clinically significant prostate cancer in patients on active surveillance (AS) with low risk and favorable intermediate-risk prostate cancer.
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Can a crisis plan boost PTSD therapy and save lives?
Symptom relief Recruiting nowThe long-term goal of this study is to reduce suicidal thoughts and behaviors among treatment-seeking individuals who also have posttraumatic stress disorder (PTSD). Prolonged exposure (PE) and crisis response plan (CRP) have demonstrated empirical support for reducing suicide at…
Phase: NA • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New study aims to reduce brain fog after radiation for skull tumors
Knowledge-focused Recruiting nowCavernous sinus meningiomas are close to optic nerve, pituitary gland, cranial nerve, and hippocampi. The doses delivered to these structures are crucial and radiotherapy of cavernous sinus meningiomas exposes patients to late secondary effects (pituitary deficit, nerve palsy, c…
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Lung cancer treatment in hours, not weeks: new One-Day radiation trial shows promise
Disease control CompletedStereotactic body radiotherapy (SBRT) has become a standard of care for medically inoperable or high-risk operable early-stage non-small cell lung cancer (NSCLC) patients. It is also increasingly used to treat lung metastases in patients with oligometastatic disease. While SBRT i…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can a neck injection boost PTSD therapy? new trial aims to find out.
Symptom relief Recruiting nowThe goal of this clinical trial is to compare the combination of Massed Prolonged Exposure (PE); a behavioral therapy for PTSD) and a stellate ganglion block (SGB; an injection of a local anesthetic into the front of the neck) with Massed Prolonged Exposure and a sham injection i…
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Symptom relief
Last updated Jun 26, 2026 13:42 UTC
-
New drug DNTH103 aims to tame muscle weakness in myasthenia gravis
Disease control OngoingThe purpose of this Phase 2 study is to evaluate the safety, tolerability, pharmacometrics, and efficacy of DNTH103 in participants with generalized myasthenia gravis (gMG).
Phase: PHASE2 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Custom 3D-printed masks aim to give kids with breathing problems a better night's sleep
Symptom relief OngoingNon-invasive ventilation (NIV) is the delivery of breathing support via a facemask. It is used to treat people whose natural breathing is ineffective. Evidence shows that, when used long-term, it improves both quality of life and life expectancy. Ventilation is delivered in the …
Phase: NA • Sponsor: Sheffield Children's NHS Foundation Trust • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Could a weekly shot stop post-transplant weight gain?
Prevention Recruiting nowIn this study, semaglutide will be compared to placebo (a look-alike inactive substance, a "sugar pill") to determine if its use will prevent weight gain after liver transplantation (LT). In addition, researchers will be testing to determine if semaglutide prevents the developmen…
Phase: PHASE2 • Sponsor: University of Virginia • Aim: Prevention
Last updated Jun 27, 2026 13:03 UTC
-
New combo therapy aims to tackle Hard-to-Treat myeloma
Disease control Recruiting nowThe purpose of this study is to establish a safe and tolerable dose of arlocabtagene autoleucel (BMS-986393) in combinations with alnuctamab, mezigdomide, iberdomide, and elranatamab in participants with relapsed and/or refractory multiple myeloma (RRMM).
Phase: PHASE1 • Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC